Pemphigus Vulgaris and Orthodontics UK

What is pemphigus vulgaris?

Pemphigus vulgaris is a rare autoimmune disease in which the body produces antibodies against desmoglein proteins that normally hold the cells of the skin and mucous membranes together. Without this adhesion, the surface layers separate easily, forming fragile blisters that break down quickly into painful, raw erosions. The mouth is the first site affected in the large majority of cases, often well before any skin blisters appear, which means dentists and orthodontists can be among the first clinicians to see early signs of the disease. It is a serious condition that requires ongoing specialist medical management, typically through dermatology or oral medicine.

Mucosal fragility and why active disease is a barrier to treatment

The hallmark of pemphigus vulgaris is extreme mucosal fragility: even gentle friction, such as a bracket edge, a wire end, or the mechanical pressure of taking impressions, can trigger new blistering and erosion in an area that was previously unaffected — a phenomenon comparable to a positive Nikolsky sign seen on clinical examination. For this reason, orthodontic treatment is not undertaken while pemphigus vulgaris is clinically active. Any elective procedure that involves manipulating or placing pressure on the oral mucosa is deferred until the disease is in a stable, well-controlled remission confirmed by the treating dermatology or oral medicine team.

Treatment timing — remission before orthodontics

Because active lesions can be worsened by mechanical trauma and healing is already impaired during a flare, orthodontists will generally only consider starting or continuing treatment once pemphigus vulgaris has been in sustained clinical remission for a period agreed with the patient's specialist team — this is a clinical judgement made case by case rather than a fixed rule. Even once treatment starts, orthodontists remain alert to any new blistering or erosion as an early sign that appliance forces or components are causing mucosal irritation, and will adjust or pause treatment accordingly.

Immunosuppressive medication and wound healing

Pemphigus vulgaris is managed with systemic immunosuppression — commonly high-dose corticosteroids in the initial phase, followed by steroid-sparing agents such as azathioprine, mycophenolate mofetil, or the monoclonal antibody rituximab, which specifically depletes the B-cells responsible for producing the damaging antibodies. These medications reduce the immune response, which can slow healing after any planned extractions or oral surgery and increase susceptibility to infection. Orthodontic planning around extractions or other invasive steps needs to take current medication and its immunosuppressive intensity into account, in liaison with the prescribing specialist.

Steroid cover and dental procedures

Patients on long-term or high-dose corticosteroids for pemphigus vulgaris may have suppressed adrenal function, meaning the body cannot mount its own stress response as effectively during a demanding dental procedure. Depending on current and recent steroid dosing, additional steroid cover may be needed before more invasive dental or orthodontic-related procedures — this should be planned with the patient's dermatology or oral medicine team rather than decided by the dental team alone, and is a routine part of coordinated care for patients on long-term systemic steroids.

Rituximab and infection risk

Rituximab is now a first-line treatment for many patients with moderate to severe pemphigus vulgaris because it can induce longer remissions than conventional immunosuppressants. It works by depleting B-cells for an extended period, which increases susceptibility to infection during and after treatment. Patients who have had or are due to have rituximab should let their orthodontist know, since the timing of any invasive dental steps — including extractions that might be needed as part of orthodontic treatment — is best coordinated around the rituximab treatment cycle with input from the prescribing team.

Choosing an appliance that minimises mucosal trauma

Where orthodontic treatment is appropriate — during confirmed remission and with specialist sign-off — appliance selection focuses on minimising any further mechanical trauma to mucosa that has a history of fragility. Clear aligners, which present a smooth, close-fitting surface without the sharp edges or protruding components of fixed brackets and wires, are often preferred for this reason where they suit the malocclusion being treated. Where fixed appliances are used, meticulous wire finishing, generous use of orthodontic wax, and close monitoring for any new erosion are essential.

Coordinating orthodontic and oral medicine care

Pemphigus vulgaris is a condition where the orthodontist should not act in isolation. Before considering any orthodontic treatment, liaison with the patient's dermatology or oral medicine consultant is needed to confirm disease is in stable remission, understand current medication and any steroid cover requirements, and agree a plan for what happens if new blistering appears during treatment. In the UK, this multidisciplinary approach is usually coordinated through a hospital oral medicine or dermatology department already managing the patient's pemphigus vulgaris.

Useful related pages

This guide is for general information only. It is not a diagnosis, treatment plan, or substitute for advice from a registered dentist or orthodontist.